QIK, actif, humain étiqueté GST, PRECISIO Kinase, recombinant, exprimé en cellules bactériulovirus infectées Sf9, > = 70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5082-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

QIK is a serine/threonine protein kinase that contains an N-terminal kinase domain, a central domain with ubiquitin-associate motif, and a C-terminal PKA ...


en savoir plus

Votre prix
£428.00 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

QIK is a serine/threonine protein kinase that contains an N-terminal kinase domain, a central domain with ubiquitin-associate motif, and a C-terminal PKA phosphorylation site. QIK can phosphorylate IRS1 and overexpression of QIK in adipocyte elevates the phosphorylation of IRS1. The QIK-mediated phosphorylation of IRS1 may modulate the efficiency of insulin signal transduction and could be responsible for insulin resistance associated with diabetes. Insulin disrupts TORC2 activity by induction of QIK which then stimulates the phosphorylation and cytoplasmic translocation of TORC2. Phosphorylated TORC2 is subsequently degraded by the 26S proteasome.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol.

Preparation Note

after opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... SIK2(23235)
mol wt~150 kDa
NCBI accession no.NM_015191
product linePRECISIO® Kinase
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity95-129 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: